Albert W. Gianchetti
Amministratore Delegato presso Xylocor Therapeutics, Inc.
Posizioni attive di Albert W. Gianchetti
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
| Presidente | - | - |
Storia della carriera di Albert W. Gianchetti
Precedenti posizioni note di Albert W. Gianchetti
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VANDA PHARMACEUTICALS INC. | Corporate Officer/Principal | 25/10/2007 | 01/12/2008 |
| GSK PLC | Corporate Officer/Principal | - | - |
Formazione di Albert W. Gianchetti
| University of Delaware | Undergraduate Degree |
| Drexel University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| VANDA PHARMACEUTICALS INC. | Health Technology |
| GSK PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Health Technology |
- Borsa valori
- Insiders
- Albert W. Gianchetti
- Esperienza
